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Summary
 
Natural killer (NK) cells exhibit cytotoxicity against variety of tumor cells and virus-infected cells
without prior sensitization and represent unique lymphocytes involved in primary host defense.
NKR-P1 is thought to be one of NK receptors mediating activation signals because cross-link-
ing of NKR-P1 activates NK cells to exhibit cytotoxicity and IFN-
 
g
 
 production. However,
molecular mechanism of NK cell activation via NKR-P1 is not well elucidated. In this study,
we analyzed the cell surface complex associated with NKR-P1 on NK cells and found that
NKR-P1 associates with the FcR
 
g
 
 chain which is an essential component of Fc receptors for IgG
and IgE. The association between FcR
 
g
 
 and NKR-P1 is independent of Fc receptor com-
plexes. Furthermore, NK cells from FcR
 
g
 
-deficient mice did not show cytotoxicity or IFN-
 
g
 
production upon NKR-P1 cross-linking. Similarly, NK1.1
 
1
 
 T cells from FcR
 
g
 
-deficient mice
did not produce IFN-
 
g
 
 upon NKR-P1 crosslinking. These findings demonstrate that the
FcR
 
g
 
 chain plays an important role in activation of NK cells via the NKR-P1 molecule.
 
N
 
K cells play a pivotal role in protective immunity. Es-
pecially, NK cells are involved in the earliest stage of
immune response because they can exhibit cytotoxicity or
cytokine production without prior sensitization (1). There-
fore, it is important to elucidate the mechanism of antigen
recognition by NK cells to understand innate immunity.
Recent analyses have revealed that various types of recep-
tors are involved in the regulation of NK cell activation (2,
3). Among these, the NKR-P1 molecule is thought to be
one of NK receptors which mediates NK cell activation
because cross-linking of NKR-P1 induces various activa-
tion signals such as, Ca
 
2
 
1
 
 flux, PI turnover and lymphokine
production (4, 5). The NKR-P1 was originally cloned from
rat NK cells (4, 5), and subsequently cloned from mouse
and human (6, 7). In mouse NK cells, NK1.1, a specific
marker of mouse NK cells, is one of NKR-P1 family mol-
ecules, NKR-P1C (8).
NK cells exhibit cytotoxicity and IFN-
 
g
 
 production
upon cross-linking of NKR-P1 molecule with specific
mAb (4, 5, 9, 10). Indeed, introduction of NKR-P1 into a
NKR-P1-deficient NK cell line restored cytotoxicity against
certain tumor cell targets (11). Furthermore, anti–NKR-P1
mAb blocked the cytotoxicity by the NKR-P1–transfected
NK cells (11). Therefore, NKR-P1 seems to be involved
in the antigen recognition by NK cells. Although the exact
 
ligand for NKR-P1 remains to be determined, NKR-P1
belongs to the C-type lectin superfamily and certain carbo-
hydrates expressed on target cells are postulated to be rec-
ognized by the NKR-P1 molecule (12).
In respect to the signaling pathway for NKR-P1, it has
been shown that NKR-P1 crosslinking stimulates PI turn-
over and raises intracellular Ca
 
2
 
1
 
 concentration (13). In ad-
dition, NKR-P1 possesses a p56
 
lck
 
-binding motif which is
represented by YxxL sequence and indeed the association
of p56
 
lck
 
 to NKR-P1 was recently reported (14). However,
essential components for NK cell activation via the NKR-P1
molecule have not been elucidated. In the present study,
we analyzed the cell surface complex associated with the
NKR-P1 molecule and found that the FcR
 
g
 
 chain is asso-
ciated with NKR-P1. Furthermore, the analysis of NK
cells from FcR
 
g
 
-deficient mice revealed that the FcR
 
g
 
chain is essential for mediating activation signals via NKR-P1.
 
Materials and Methods
 
Mice.
 
FcR
 
g
 
-deficient (
 
g
 
2
 
/
 
2
 
)
 
1
 
 mice with C57BL/6 background
were established by gene targeting using a C57BL/6 origin ES cell
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Functional Association of FcR
 
g
 
 with NKR-P1
 
line BL6/III (15) in our laboratory (Park, S.Y. et al., manuscript sub-
mitted, 16, 17) and maintained in our animal facility in SPF condition.
 
NK Cell Preparation.
 
NK cells were purified as previously de-
scribed (18). In brief, NK cells were purified from spleen of 6–8-
wk-old C57BL/6 mice. Splenocytes were mixed with anti-CD4
mAb (GK1.5) and anti-CD8 mAb (53.6.7), and incubated with
magnetic beads (Advanced Magnetics, Inc., Cambridge, MA)
coupled with goat anti–mouse IgG Ab and goat anti–rat IgG Ab
(Cappel, Organon Teknika Co., West Chester, PA) to remove
surface Ig (sIg)
 
1
 
 B cells and CD4
 
1
 
 and CD8
 
1
 
 T cells. The resid-
ual cells were then stained with PE-anti-NK1.1 (PK136) mAb
and FITC-anti-CD3
 
e
 
 (145-2C11) mAb (Pharmingen, San Di-
ego, CA) and NK1.1
 
1
 
 CD3
 
2
 
 cells were sorted by FACStar
 
plus
 
Ò
 
(Becton Dickinson, Mountain View, CA). The purified NK cells
were cultured in RPMI-1640 supplemented with 10% FCS, kan-
amycin (100 
 
m
 
g/ml) and 5 
 
3
 
 10
 
2
 
5
 
 M 2-ME in the presence of
1,000 U/ml human recombinant IL-2 (kindly provided by Dr.
Junji Hamuro, Ajinomoto Co. Inc., Kawasaki, Japan) for 5 d.
 
Flow Cytometric Analysis of NK Cells.
 
CD4
 
2
 
CD8
 
2
 
sIg
 
2
 
 sple-
nocytes prepared as described above were cultured for 4 d in the
presence of 1,000 U/ml IL-2. The cultured cells were first stained
with FITC–anti-Fc
 
g
 
RIII (2.4G2) mAb. Then, the cells were mixed
with Biotin–anti-CD3
 
e
 
 and PE–anti-NK1.1 mAbs followed by
Quantum-red streptavidin (Sigma Chem. Co., St. Louis, MO).
 
NK1.1
 
1
 
 T Cell Preparation.
 
Basically, NK1.1
 
1
 
 T cells were
prepared as previously described (10). Thymocytes were treated
with anti-HSA mAb (J11d) followed by complement treatment.
The resultant cells were incubated with anti-CD8 and anti–MEL-
14 mAb. Thereafter, CD8
 
1
 
 MEL-14
 
1
 
 cells were removed by use
of magnetic beads coupled with goat anti–rat IgG Ab. The resid-
ual cells were cultured for 3 d in the presence of 1,000 U/ml IL-2.
Thereafter, cells were stained with PE–anti-NK1.1 mAb and
FITC–anti-CD3
 
e
 
 mAb. The stained cells were sorted into
NK1.1
 
1
 
CD3
 
1
 
 cells. The sorted cells were further cultured for 2 d
in the presence of 1,000 U/ml IL-2 and used for functional analysis.
 
Surface Biotinylation, Immunoprecipitation and Western Blotting.
 
Cells were surface biotinylated as previously described (19). Bio-
tinylated cells were lysed with a lysis buffer containing 1% digito-
nin, 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 10 
 
m
 
g/ml apro-
tinin, 10 
 
m
 
g/ml leupeptin, 1 mM PMSF, 10 mM iodoacetamide,
at a concentration of 1 
 
3
 
 10
 
7
 
 cell/ml. Immunoprecipitation was
performed with anti-CD3
 
e
 
 or anti-NK1.1 mAbs. Immunopre-
cipitates were separated on two-dimensional nonreducing and re-
ducing SDS-PAGE and transferred onto a polyvinylidene difluo-
ride (PVDF) membrane (Immobilon-P; Millipore Corporation,
Bedford, MA). The biotinylated proteins were detected using strep-
tavidin-peroxidase (VECSTAIN Elite ABC kit; Vector Laborato-
ries Incorporated, Burlingame, CA), the ECL system (Amersham
International, Buckinghamshire, England), and autoradiography.
After termination of chemiluminescence, the membrane was blot-
ted with anti-FcR
 
g
 
 Ab followed by peroxidase-labeled anti–rab-
bit Ab (Amersham) and detected by the ECL system.
 
NKR-P1 and TCR Stimulation.
 
(Fab)
 
9
 
2
 
 fragment of anti-
NK1.1 mAb was immobilized on a 96-well flat-bottomed culture
plate (Coaster, Cambridge, MA) by incubating for 2 h at 37
 
8
 
C at
a concentration of 50 
 
m
 
g/ml in PBS. Similarly, anti–TCR-
 
b
 
mAb (H57-597) was immobilized at a concentration of 100 
 
m
 
g/ml.
1 
 
3
 
 10
 
5
 
 NK cells cultured for four days in the presence of IL-2
were stimulated with the immobilized anti-NK1.1 mAb, or with
recombinant mouse IL-12 (4.9 
 
3
 
 10
 
6
 
 U/mg, generously supplied
from Genetics Institute, Inc., Cambridge, MA) for 2 d.
 
Measurement of IFN-
 
g
 
 and IL-4.
 
IFN-
 
g
 
 and IL-4 in the cul-
ture supernatant was measured by ELISA with standard protocol.
Anti–IFN-
 
g
 
 (R4-6A2) and anti–IL-4 (BVD4-1D11) mAb was
coated to capture IFN-
 
g
 
 and IL-4 and the captured IFN-
 
g
 
 and
IL-4 were detected with biotinylated anti–IFN-
 
g
 
 (XMG1.2) and
anti–IL-4 (BVD6-24G2) mAbs. These antibodies were purchased
from Pharmingen. Concentrations of IFN-
 
g
 
 and IL-4 were de-
termined with recombinant IFN-
 
g
 
 and IL-4 as a standard.
 
Redirected Cytotoxicity of NK Cells.
 
Cytotoxic assay was done
basically as previously described (20). Briefly, freshly isolated
CD4
 
2
 
 CD8
 
2
 
 HSA
 
2
 
 sIg
 
2
 
 population was used as NK cell en-
riched population. About 50% of this population expressed the
NK1.1 molecule. These NK cells were incubated at 4
 
8
 
C for 30
min in the presence or absence of anti-NK1.1 mAb. Thereafter,
 
51
 
Cr-labeled FcR-expressing P815 cells were added and cultured
at 37
 
8
 
C for 4 h and analyzed the amount of Cr
 
51
 
 released in the
culture supernatant. Specific cytotoxicity was calculated as previ-
ously described (20).
 
Results
 
To elucidate signaling pathways for NK cell activation
through NKR-P1, we analyzed the NKR-P1-associated
complex on the cell surface using an NK1.1-expressing T
cell line CTLL-2. CTLL-2 cells were surface-biotinylated
and the cell lysate was immunoprecipitated with anti-
NK1.1 or anti-CD3
 
e
 
 mAbs, followed by analysis on two
dimensional nonreducing and reducing SDS-PAGE.
As shown in Fig. 1 
 
A
 
, immunoprecipitation with anti-
NK1.1 mAb revealed that a 9-kD homodimer was copre-
cipitated with NK1.1 molecule. In contrast, when the TCR
complex was precipitated with anti-CD3
 
e
 
 mAb, CD3
 
z
 
 ho-
modimers, CD3
 
z
 
-FcR
 
g
 
 heterodimers and a small amount
of FcR
 
g
 
 homodimers were observed as previously reported
(21). Interestingly, the 9-kD homodimers coprecipitated with
NK1.1 appeared to be identical to FcR
 
g
 
 within the TCR
complex. Indeed, the homodimers coprecipitated with NK1.1
were blotted with anti-FcR
 
g
 
 Ab similarly to FcR
 
g
 
 ob-
served in the CD3e-immunoprecipitates (Fig. 1 B). The as-
sociation of the FcRg chain with the NKR-P1 molecule
was also observed in a rat NK cell line, RNK-16 (data not
shown). We next analyzed normal NK cells to generalize
the physical association between FcRg and NKR-P1 in
normal NK cell population. Similar to CTLL-2, when
NK1.1 was immunoprecipitated from IL-2 activated NK
cells, the FcRg homodimer was coprecipitated with
NK1.1 (Fig. 2). Collectively, these data indicate that the as-
sociation of FcRg with NKR-P1 is generally observed for
NK cells in vivo.
To elucidate the physiological role of the association be-
tween FcRg and NKR-P1 particularly on signal transduc-
tion in NK cells, NK cells were prepared from g2/2 mice
and analyzed for NKR-P1 expression and NKR-P1–medi-
ated NK cell activation. When CD42CD82sIg2 spleno-
cytes from g2/2 mice were stained with anti-NK1.1 and
anti-CD3e mAbs, normal development of NK cells
(NK1.11CD32) was observed (data not shown). When ex-
pression of FcgRIII on IL-2–expanded NK cells was ana-
lyzed, NK cells from g2/2 mice did not express FcgRIII
(Fig. 3). In addition, the expression level of NK1.1 on the
cell surface of IL-2–expanded NK cells from g2/2 mice1959 Arase et al.
was significantly lower than that of NK cells from g1/1 and
g1/2 mice. However, the difference of NK1.1 expression
between g2/2 and g1/2 mice was marginal when freshly
isolated NK cells were analyzed (data not shown). This
suggested that FcRg is not absolutely required for but af-
fects the surface expression of the NKR-P1 molecule.
Recently, we have shown that cross-linking of NKR-P1
on NK cells with anti-NK1.1 mAb induced not only cyto-
toxicity but also IFN-g production (10). Thus, we stimu-
lated purified NK cells from g2/2 mice with immobilized
F(ab)92 fragment of anti-NK1.1 mAb in order to avoid the
binding of the Ab to Fc receptors, and measured the
amount of IFN-g produced in the culture supernatant. Sur-
prisingly, NK cells from g2/2 mice did not produce IFN-g
at all upon NKR-P1 cross-linking, whereas NK cells from
g1/1 mice produced a large amount (Fig. 4). In contrast,
NK cells from both g2/2 and g1/1 mice produced almost
equal amount of IFN-g upon IL-12 stimulation. This sug-
gests that the defect of IFN-g production upon NKR-P1
cross-linking by NK cells from g2/2 mice is not due to the
inability of IFN-g production but the signaling defect via
NKR-P1.
Because NK1.11 T cells also produce IFN-g but not IL-4
upon NKR-P1 cross-linking (10), we also analyzed the
function of NK1.11 T cells in g2/2 mice. As we have pre-
Figure 1. Association of the FcRg chain with the NKR-P1 molecule
on the cell surface of CTLL-2 cell line. (A) CTLL-2 cells were surface-bio-
tinylated and the cell lysate was immunoprecipitated with anti-NK1.1
mAb or anti-CD3e mAb and analyzed on two-dimensional nonreducing
(NR) and reducing (R) SDS-PAGE. Biotinylated proteins were detected
by an ECL. (B) FcRg chain was detected by blotting the membrane with
anti-FcRg Ab after immunoprecipitation with anti-NK1.1 or anti-CD3e
mAbs. FcRg homodimer (g-g) and CD3z-FcRg heterodimers (z-g)
were indicated.
Figure 3. Loss of the cell surface expression of FcgRIII on NK cells
from g2/2 mice. CD42CD82HSA2sIg2 splenocytes from g1/1, g1/2 and
g2/2 mice were cultured for 4 d in the presence of 1,000 U/ml IL-2. The
cultured cells were stained with FITC–anti-FcgRIII, PE–anti-NK1.1 and
Quantum red-anti-CD3e mAbs and the expression of FcgRIII and
NK1.1 on the CD32 population was illustrated. Representative data from
five independent experiments are shown.
Figure 4. Defect of IFN-g production by NK cells from g2/2 mice
upon stimulation with NK1.1 cross-linking. NK cells from g1/1 (closed
bar) and g2/2 (open bar) mice were stimulated with immobilized (Fab)92
fragment of anti-NK1.1 mAb or 1 ng/ml IL-12 and IFN-g produced in
the culture supernatant was measured. Data are presented as mean 6 SD
of triplicate culture.
Figure 2. Association of the FcRg chain with the NKR-P1 molecule
in IL-2–expanded NK cells. NK cells from normal mice expanded for 1 wk
in the presence of IL-2 and were surface-biotinylated. The cell lysate of
them was immunoprecipitated with anti-NK1.1 mAb ((Fab)92 fragment)
and analyzed on two-dimensional nonreducing (NR) and reducing (R)
SDS-PAGE. Biotinylated proteins were detected as Fig. 1 A. FcRg ho-
modimer (g-g) was indicated.1960 Functional Association of FcRg with NKR-P1
viously reported (22), NK1.11 T cells develop normally in
g2/2 mice. NK1.11 T cells were prepared from g1/1 and
g2/2 mice and stimulated with immobilized anti-NK1.1
mAb (Fig. 5). Similar to NK cells, NK1.11 T cells from
g2/2 mice did not produce IFN-g upon NKR-P1 cross-
linking whereas these cells from g1/1 mice produced a sig-
nificant amount of IFN-g. In contrast to the stimulation
through NKR-P1, NK1.11 T cells from both g1/1 and
g2/2 mice produced IFN-g and IL-4 upon TCR cross-
linking. These observations demonstrate that the FcRg
chain is required for IFN-g production via NKR-P1 cross-
linking both in NK cells and NK1.11 T cells.
We also investigated the involvement of FcRg in the
NKR-P1–mediated cytotoxicity of NK cells. Since NKR-P1
is known to induce redirected cytotoxicity against FcR-
expressing cells, we analyzed cytotoxicity of NK cells against
FcR-expressing P815 cells in the presence of anti-NK1.1
mAb (Fig. 6). NK cells from g1/1 and g1/2 mice showed
increased cytotoxicity against P815 cells in the presence of
anti-NK1.1 mAb, whereas NK cells from g2/2 mice failed
to enhance cytotoxicity. These results demonstrate that
FcRg is involved in both IFN-g production and cytotox-
icity upon stimulation through the NKR-P1 molecule.
The failure of NK cell activation through NKR-P1 in
g2/2 mice is likely due to a defect in signaling pathway of
the NKR-P1 molecule. However, since the NK1.1 expres-
sion on the cell surface of NK cells from g2/2 mice is
slightly lower than that of g1/2 and g1/1 mice, it might be
attributed to the low expression of the cell surface NKR-P1.
To clarify these possibilities, we prepared two populations
of NK cells from normal mice expressing low or high level
of NKR-P1 (NKR-P1lo and NKR-P1hi, respectively) by cell
sorting. The expression level of NKR-P1 on the NKR-
P1lo population was almost identical to that of NK cells from
g2/2 mice. (Fig. 7, A and B). Then, we stimulated these
NK cell populations with immobilized anti-NK1.1 mAb.
NKR-P1lo NK cells from g1/1 mice produced significant
amount of IFN-g upon NKR-P1 cross-linking, although
the amount of IFN-g was lower than that by NKR-P1hi
NK cells (Fig. 7 C). In contrast, NK cells from g2/2 mice did
not produce any detectable level of IFN-g upon NKR-P1
cross-linking. These observations confirm the crucial role
of FcRg in signaling pathway through NKR-P1 for NK
activation and also demonstrate that FcRg is partly in-
volved in the expression of the cell surface NKR-P1.
Discussion
FcRg was originally identified in the FceRI complex
and found to play an essential role in the expression and
signaling of FceRI (23). FcRg was also found to be re-
quired for the expression and function of FcgRI, FcgRIII
and FcaR (24, 25). On the other hand, we found that
FcRg also associates with the TCR complexes in two types
of T cells. One is T cells in epithelia such as CD8aa1
TCR-g/d1 intestinal intraepitherial lymphocytes and TCR
g/d1 dendritic epidermal cells and the association with
FcRg in these cells was shown in vivo from the analysis of
Figure 5. Defect of IFN-g production by
NK1.11 T cells from g2/2 mice upon stim-
ulation with NK1.1 cross-linking. NK1.11
T cells from g1/1 (closed bar) and g2/2 (open
bar) mice were stimulated with immobilized
anti-NK1.1 mAb or anti-TCRb mAb and
IFN-g and IL-4 produced in the culture su-
pernatant was measured. Data are presented
as mean 6 SD of triplicate culture.
Figure 6. Defect of NK1.1
mediated cytotoxicity by NK
cells from g2/2 mice. Cytotoxic-
ity of NK cells from g1/1, g1/2,
and g2/2 mice against P815 cell
line was analyzed in the presence
(open circles) or absence (closed cir-
cles) of anti-NK1.1 mAb. Data
are presented as mean 6 SD of
triplicate assay.1961 Arase et al.
CD3z-deficient mice (26). The second population is
NK1.11 TCR-a/b1 T cells. (22). However, these T cells
obtained from g2/2 mice showed no clear defect in func-
tion upon TCR activation, although the expression level of
the TCR complex was slightly decreased (27). Accord-
ingly, it is striking that NK cells and NK1.11 T cells from
g2/2 mice show no response upon NKR-P1 cross-linking
in spite of normal development. This finding suggests that
CD3z expressed in NK cells and NK1.11 T cells can not
be replaced for FcRg in signaling through NKR-P1, be-
cause NKR-P1 bind only to FcRg dimers but not to
CD3z homodimers or CD3z-FcRg heterodimers. In con-
trast, T cells show no functional defect in g2/2 mice prob-
ably because the TCR complexes can utilize both CD3z
and FcRg and CD3z can replace for FcRg in the TCR
complexes of g2/2 mice.
FcgRIII which is associated with FcRg is known to ac-
tivate NK cells upon cross-linking. Therefore, there is a
possibility that NKR-P1 associates with FcgRIII on the cell
surface and delivers activating signal through FcRg which
is coupled with FcgRIII. However, this is unlikely because
of two reasons. One is that FcgRIII was not expressed on
the cell surface of CTLL-2 (data not shown), whereas the
association between FcRg and NKR-P1 was readily de-
tected in the CTLL-2 (Fig. 1). Second, we used the (Fab)92
fragment of anti-NK1.1 mAb for cross-linking of NKR-P1
and thus it is unlikely that immobilized anti-NK1.1 mAb
activated FcgRIII. Taken together, the association of FcRg
with NKR-P1 is essentially independent of FcgRIII.
Recent analysis revealed that activation of NK cells is
negatively regulated by several killer inhibitory receptors
(KIR) possessing immunoreceptor tyrosine-based inhibition
motif (ITIM) (28, 29). These receptors such as p58,
NKG2, and Ly49 recognize specific MHC class I molecule
and deliver inhibitory signal for the cytotoxicity by NK
cells (30–32). Furthermore, association of SHP-1 phospha-
tase with ITIM is important for the inhibition of NK cell
activation (28, 29). Although the coprecipitation of CD3z
or FcRg with p58 was suggested, functional significance
remained unclear (33). On the other hand, only a few re-
ceptors which deliver positive signal for NK cell activation
have been identified such as NKR-P1 and CD94/NKG2-C
(34) and the molecular mechanism of NK cell activation
through these receptors remains unclear. Under these cir-
cumstances, it is noteworthy that FcRg, a signal transduc-
ing chain possessing immunoreceptor tyrosine-based acti-
vation motif (ITAM), is involved in signal transduction
through NKR-P1. Because Syk tyrosine kinase interacts with
the phosphorylated ITAM of FcRg and is involved in NK
cell activation through FcR (35, 36), it is likely that Syk
also mediates the activating signal through NKR-P1 in NK
cells. Furthermore, it has been shown that Lck directly as-
sociates with NKR-P1 (14). Taken together, both Syk and
Lck seem to play an important role in mediating activation
signals through NKR-P1 in NK cells.
Although the NKR-P1 molecule belongs to the C-type
lectin superfamily and has been shown to have affinity to
specific carbohydrates (12), the exact function of NKR-P1
has remained unclear. This is partly because antibodies
against mouse or rat NKR-P1 do not block cytotoxicity of
NK cells against YAC-1, a NK-sensitive target cell line. In
addition, NK cells from g2/22 mice showed normal cy-
totoxicity against representative NK targets (data not shown).
However, the failure of blocking with anti–NKR-P1 mAb
can be explained by the possible redundancy of NKR-P1
family molecules on NK cells. Indeed, recent observation
that introduction of NKR-P1 into a NKR-P1–deficient
NK cell line restored cytotoxicity against specific tumor cell
targets and the restored cytotoxicity was blocked by anti–
NKR-P1 mAb (11) strongly suggested that NKR-P1 is in-
volved in the recognition of specific target molecules on NK
cells. A couple of reports demonstrating that anti-NK1.1
mAb blocked cytotoxicity of NK cells against specific tar-
gets also support this idea (37, 38). Further analysis of NK
cells in g2/2 mice may elucidate novel function of NKR-
P1 molecule in the host defence.
Figure 7. Activation defect of NK cells from FcRg-deficient mice
upon NKR-P1 crosslinking is not due to the low level of NKR-P1 ex-
pression. (A) NK1.1 expression on NK cells from g1/1 and g2/2 mice.
NK cells from g1/1 or g2/2 mice were stained with anti-NK1.1 mAb
(solid line) or control Ab (dotted line). (B) Preparation of NK cell popula-
tion expressing high (hi) and low (lo) level of NKR-P1 from wild-type
mice. (C) Production of IFN-g by NK cell population expressing low
NKR-P1 upon stimulation with immobilized anti-NK1.1 mAb. Two
NK cell populations expressing high (NK1.1hi) and low (NK1.1lo) level of
NK1.1 as shown in B from g1/1 mice and NK cells from g2/2 mice were
stimulated with immobilized (Fab)92 fragment anti-NK1.1 mAb and IFN-g
production was measured.1962 Functional Association of FcRg with NKR-P1
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